If the low TF prevalences observed at impact survey are sustained in the absence of antibiotic pressure over the subsequent two years of surveillance [35], it may be reasonable to believe that one round of well-conducted, relatively high-coverage MDA is sufficient to eliminate active trachoma in Malawi districts that are hypoendemic at baseline. This evidence concerns the gene TF and inclusion conjunctivitis.